Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.

Scheuble AM, Lordick F, Maki RG

Open source

DOI
10.1016/j.esmogo.2026.100397
Published
2026 Sep
Container
ESMO gastrointestinal oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmogo.2026.100397,
  title = {Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.},
  author = {Scheuble AM and Lordick F and Maki RG},
  year = {2026},
  journal = {ESMO gastrointestinal oncology},
  doi = {10.1016/j.esmogo.2026.100397},
  url = {https://doi.org/10.1016/j.esmogo.2026.100397}
}

RIS

TY  - JOUR
TI  - Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.
AU  - Scheuble AM
AU  - Lordick F
AU  - Maki RG
PY  - 2026
JO  - ESMO gastrointestinal oncology
DO  - 10.1016/j.esmogo.2026.100397
UR  - https://doi.org/10.1016/j.esmogo.2026.100397
ER  - 

APA

AM, S., F, L., & RG, M. (2026). Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2026.100397

Source records